Originally developed for the treatment of type 2 diabetes mellitus, GLP-1 receptor agonists (GLP-1RAs) have demonstrated substantial efficacy in reducing body weight among individuals without diabetes [42,43]. The gene discussed is GLP1R; the disease is diabetes mellitus.